InvestorsHub Logo
Followers 3
Posts 2106
Boards Moderated 1
Alias Born 11/02/2016

Re: None

Thursday, 12/02/2021 11:28:50 AM

Thursday, December 02, 2021 11:28:50 AM

Post# of 16682
Oct 14, 2020






So nearly 14 months ago they were Researching FDA EUA Requirements, how many requirements did they need ? How many have been met ? Did they ever get successful results for that testing platform ?

Is there a study currently happening ? Estimated time to finish ? Have they gotten a manufacturing company to help out ?

Or are they dead in the water after all these years......




NanoLogix Is Researching FDA EUA Requirements For COVID-19 Testing Related to Recently Allowed Patent

1st For Whole Virus Detection, 2nd For Antibody Detection

NanoLogix Welcomes David R. Barnhizer as Vice President For Strategic Analysis and Development

NanoLogix is researching FDA requirements for EUA's for two of the 25 covered claims in the recently allowed patent application focused upon Rapid Virus Detection. Now that there has been allowance for issue of the patent with all 25 claims allowed, NanoLogix can justify devoting resources to this process and specifics.

Upon successful results for work currently being performed by a third party to apply NanoLogix technology to a separate testing platform for COVID19 detection, other applications may follow. Once the patent is issued we will reveal the broad and detailed extent of allowed claims for this technology.